Marathon Asset Management

Theratechnologies Inc., a biopharmaceutical company, engages in the discovery of therapeutic products for commercialization. The company's proprietary technologies include Long Acting Peptides, a peptide stabilization technology that increases the target protein's resistance to enzymatic degradation. Its lead product is tesamorelin, which completed its phase III clinical trial for the treatment of HIV-associated lipodystrophy and is in phase II clinical trials for the treatment of mild cognitive impairment and growth hormone deficient abdominal obesity. The company also develops Acute kidney injury, a preclinical stage product. It has a license agreement with PDC Biotech GmbH to use the antagonists of the prostaglandin F2a receptor in pre-term labor and primary dysmenorrheal; and OctoPlus N.V. to develop and commercialize GLP-1 portfolio of analogues. The company also has a collaboration and licensing agreement with EMD Serono, Inc. for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded in 1993 and is headquartered in Montreal, Canada.

Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious, rare, and life-threatening diseases with unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.

BigBear.ai is a decision dominance serving the national defense and intelligence communities. The Company delivers high-end capabilities across the data and digital spectrum to deliver information superiority and decision support. BigBear.ai provides a comprehensive suite of solutions including artificial intelligence and machine learning, data science, advanced analytics, offensive and defensive cyber, data management, cloud solutions, digital engineering, and systems integration.

Avenger Flight Group is a provider of commercial aviation simulation and training. Avenger provides simulation training to domestic and international airlines using state of the art simulators located in strategically convenient locations in Ft. Lauderdale, Las Vegas, Mexico City and Dallas. Avenger also provides classroom training for trainers and pilots.

Dermavant Sciences is a biotechnology company focused on dermatology.

Healogics is an outsourced operator of wound care centers in hospitals providing wound care services by contacting physicians. In addition to the company’s network of outpatient centers, the company partners with over 300 skilled nursing facilities to care for patients with chronic wounds and provides inpatient consults at more than 60 partner hospitals.

Europcar is the largest car rental company in Europe and currently has 2825 locations in 143 different countries. Europcar offices in Germany, France, Italy, Spain, Portugal and the United Kingdom are run centrally by Europcar in France, while all other countries are franchisees.

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.

Sipex Corporation engages in the design, manufacture, and marketing of analog integrated circuits (ICs). It offers power management products, including white LED drivers, DC/DC regulators, and controllers to regulate, control, monitor, or provide the reference voltage for a system or portion of a system. The company also provides interface products that facilitate the transfer of digital signals between or within electronic systems, as well as ensure connectivity between networks, computers, and digital peripherals and consumer portable devices that connect to them. In addition, it offers optical storage products, including photo-detector ICs, advanced power control ICs, and laser diode drivers.